ABBOTT LABORATORIES — Income Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+7.8% +$806M
$11.16B
Cost of Revenue↑+9.4% +$422M
$4.89B
Gross Profit
—
R&D↑+7.1% +$51M
$767M
SG&A↑+22.2% +$679M
$3.74B
D&A↑+13.4% +$45M
$381M
Operating Income↓-20.6% -$348M
$1.34B
EBITDA↓-14.9% -$303M
$1.73B
Interest Expense↑+32.8% +$43M
$174M
Interest Income↑+29.3% +$24M
$106M
Other Income/Expense↑+28.4% +$38M
$172M
Pretax Income↓-18.5% -$329M
$1.45B
Tax Provision↓-17.9% -$81M
$372M
Net Income↓-18.7% -$248M
$1.08B
Gross Margin
—
Operating Margin↓-4.3pts
12.0%
Net Margin↓-3.1pts
9.6%
Effective Tax Rate↑+0.2pts
25.7%
ETR (Continuing Operations)↑+114.0pts
22.9%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-0.2pts
0.3%
ETR Foreign Differential (pp)↑+1.8pts
-1.8%
Operating Lease Cost↑+18.8% +$25M
$158M
Revenue YoY Variation↑+3.8pts
7.8%
Income YoY Variation↓-42.7pts
-20.6%
Revenue QoQ Variation↑+3.0pts
-2.6%
Income QoQ Variation↓-28.8pts
-40.2%